Suing Opioid Companies for Health Costs

Summary#

• This bill lets the Yukon and the federal government sue opioid makers, wholesalers, and consultants to recover public health care costs tied to opioid harms.

• It makes it easier to bring large, population-wide claims using statistics, instead of proving each person’s case one by one.

• Key changes and impacts:

  • Creates a direct right for the Yukon and Canada to sue for health costs linked to opioid-related disease, injury, or addiction.
  • Allows “aggregate” lawsuits that rely on population data; individual patient identities and records are protected, with only anonymized samples allowed under court order.
  • Sets legal presumptions and uses market share to divide liability among companies for aggregate claims; companies that acted together can be jointly liable.
  • Lets courts assign partial liability based on each company’s contribution to the risk (for non-aggregate cases).
  • Makes directors and officers personally liable if they directed or allowed the wrongdoing, with a defense if they used reasonable care.
  • Extends time limits to sue (up to 15 years), applies retroactively, can revive some dismissed cases, and covers ongoing multi-province cases that include Yukon.
  • Allows regulations to define which opioid drugs are covered. The schedule includes drugs like oxycodone, fentanyl, morphine, codeine (with some exceptions), hydromorphone, and others.

What it means for you#

• Residents and patients

  • No change to your ability to get a legal opioid prescription. The bill targets companies, not patients.
  • Your personal health records stay private in these cases; courts can only order anonymized samples with names removed.
  • If you were harmed, this law does not block you from bringing your own lawsuit. The government’s case is separate.

• Families affected by opioids

  • The Yukon may seek money from opioid companies to cover public health costs. This money would go to the government, not directly to individuals.

• Taxpayers

  • If lawsuits succeed or settle, recovered funds could help offset health care spending related to opioids.

• Health care providers

  • No new duties for prescribers are created. Clinics and hospitals generally won’t have to turn over individual files, except for anonymized samples if a court orders it.

• Businesses in the opioid supply chain

  • Manufacturers, wholesalers, and consultants face greater legal risk, including potential joint liability and liability based on market share.
  • Company directors and officers can be personally liable if they directed or allowed the wrongdoing, unless they can show they used reasonable care.

Expenses#

No publicly available information.

Proponents' View#

• Helps hold opioid companies responsible for misleading promotion or other wrongdoing that drove addiction and overdose.
• Recovers public health costs for treatment, emergency response, and other services related to opioid harms.
• Makes complex cases doable by using population data and legal presumptions, instead of proving harm person by person.
• Prevents company leaders from hiding behind the corporate structure when they allowed or directed harmful actions.
• Aligns Yukon with similar laws elsewhere and supports Yukon’s role in ongoing Canada-wide cases and settlements.

Opponents' View#

• Retroactive rules and longer time limits may be unfair and could face constitutional or legal challenges.
• Presumptions and reliance on statistics may lower the usual standard of proof and risk sweeping in companies that were less at fault.
• Broad liability, including for directors and wholesalers, could worry legitimate businesses and complicate normal operations.
• Lawsuits can take years, cost money, and have uncertain outcomes, which may delay any financial benefits.
• Overriding or reopening earlier agreements with companies could create legal conflicts and uncertainty.